Synthesis and antioxidant properties of novel benzimidazoles containing substituted indole or 1,1,4,4-tetramethyl-1,2,3,4-tetrahydro-naphthalene fragments

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 20, Issue 4, 2005, Pages 325-331

  Ateş Alagöz, Zeynep ^a   Kuş, Canan ^a   Çoban, Tülay ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Antioxidant; Benzimidazole; Free radical; Indole; Retinoids; Synthesis

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; 1,1,4,4 TETRAMETHYL 1,2,3,4 TETRAHYDRONAPHTHALENE DERIVATIVE; ANTIOXIDANT; BENZIMIDAZOLE DERIVATIVE; SUPEROXIDE; SUPEROXIDE DISMUTASE; TETRALIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; PRIORITY JOURNAL;

ANTIOXIDANTS; BENZIMIDAZOLES; BIPHENYL COMPOUNDS; CYTOCHROME REDUCTASES; FREE RADICAL SCAVENGERS; HYDRAZINES; NAPHTHALENES; SUPEROXIDES; XANTHINE; XANTHINE OXIDASE;

EID: 24644453863     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360500131706     Document Type: Article

References (35)

1. McCord JM. N Engl J Med 1986;312:159-162.
2. Olanow CW. Neurology 1990;40(Suppl. 3):32-37.
3. Martinez-Cayuela M. Biochimie 1955;77:147-161.
4. Schreck R, Bauerle RA. Trends Cell Biol 1991;1:39-42.
5. Fridovich I. Science 1978;201:875-880.
6. Dong Y, Venkatchalam TK, Narla RK, Trieu VN, Sudbeck EA, Uckun F. Free Rad Biol Med 2000;10:87-90.
7. Karbownik M, Reiter RJ. Proc Soc Exp Biol Med 2000; 225:9-22.
8. Chomienne C, Fenaux P, Degos I. FASEB J 1996;10:1025-1030.
9. Sporn MB, Roberts AB, Roche NS, Kagechika H, Shudo K. J Am Acad Derm 1986;15:756-764.
10. Ates-Alagöz Z, Büyükbingöl E. Heterocycl Commun 2001;7:455-460.
11. Ateş Z, Süzen S, Büyükbingöl E, Can-Eke B, Işcan M. Il Farmaco 1997;52(11):703-706.
12. Ates-Alagöz Z, Can-Eke B, Çoban T, Iscan M, Buyukbingol E. Arch Pharm Pharm Med Chem 2004;337:188-192.
13. Eyrolles L, Kagechika H, Kawachi E, Fukasawa H, Iijima T, Matsushima Y, Hashimoto Y, Shudo K. J Med Chem 1994;37:1508-1571.
14. Kuş C, Ayhan-Kilcigil G, Can Eke B, Işcan M. Arch Pharm Res 2004;27:156-163.
15. Ayhan-Kilcigil G, Kuş C, Çoban T, Can-Eke B, Işcan M. J Enz Inhib Med Chem 2004;19(2):129-135.
16. Can-Eke B, Puskullu MO, Buyukbingol E, Iscan M. Chemico-Biol Interact 1998;113:65-67.
17. Kuş C, Göker H, Altanlar N. Arch Pharm Pharm Med Chem 2001;334:361-365.
18. Sanna P, Carta A, Loriga M, Zanetti S, Sechi L. Il Farmaco 1998;53:455-461.
19. Büyükbingöl E, Süzen S, Klopman G. Il Farmaco 1994;49(6):443-447.
20. McCord J, Fridowich I. J Biol Chem 1969;243:6049-6055.
21. Blois MS. Nature 1958;181:1199-1200.
22. Ghose AK, Crippen GM. J Chem Inf Comput Sci 1987;27:21-35.
23. Viswanadhan VN, Ghose AK, Revankar GR, Robins RK. J Chem Inf Comput Sci 1989;29:163-172.
24. Schaefer DM, Liu Q, Faustman C, Yin MC. J Nutr 1995;125:1792-1798.
25. Kombrust DJ, Mavis RD. Mol Pharmacol 1980;17:408-414.
26. Parke DV, Ionnides C, Lewis DF. Can J Physiol Pharmacol 1991;69:537-549.
27. Dix TA. J Chem Res Toxicol 1993;6:2-18.
28. Dündar B, Bozdaǧ-Dündar O, Can-Eke B, Coban T, Iscan M, Buyukbingol E. Pharmazie 2002;57:438-441.
29. Ölgen S, Coban T. Arch Pharm Pharm Med Chem 2002;7:331-338.
30. Ohkawa S, Terao S, Terashita Z, Shibouta Y, Nishikawa K. J Med Chem 1991;34:267-276.
31. Xanthopoulou NJ, Kourounakis AP, Spyroudis S, Kourounakis PN. Eur J Med Chem 2003;38:621-626.
32. Halliwell B. Nutrition Rev 1994;52:253-265.
33. Cos P, Ying L, Calomme M, Hu JP, Cimanga K, Poel BV, Pieters L, Vlietinck AJ, Berghe DV. J Nat Prod 1998;61:71-76.
34. Magnani L, Gaydou EM, Hubaud J-C. Anal Chim Acta 2000;411:209-216.
35. Lee SE, Hwang HJ, Ha J-S, Jeong H-S, Kim JH. Life Sci 2003;73:167-179.